Reposted by Firstname Lastname #FuckTrump
@simmaronresearch.bsky.social NIH R01 Grant: New 5-year NIH funding will study mTOR dysfunction in ME/CFS, building on Simmaron’s rapamycin research; a placebo-controlled rapamycin trial and biomarker test are also planned www.simmaronresearch.com
simmaronresearch.com
Simmaron Research
Simmaron Research plays a key role in developing scientific research to improve diagnosis, treatment and medical understanding of ME/CFS and other neuroimmune diseases.